Seascape Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.15M Buy
31,122
+1,334
+4% +$138K 0.75% 48
2026
Q1
$2.88M Buy
29,788
+353
+1% +$36.2K 0.83% 45
2025
Q4
$3.12M Buy
29,435
+3,253
+12% +$377K 0.89% 46
2025
Q3
$3.33M Buy
26,182
+2,014
+8% +$240K 0.95% 42
2025
Q2
$2.96M Sell
24,168
-5
-0% -$571 0.93% 42
2025
Q1
$2.45M Buy
24,173
+963
+4% +$94K 0.85% 42
2024
Q4
$2.14M Buy
+23,210
New +$2.28M 0.75% 48

Other funds holding EHC

Seascape Capital Management's EHC Position: Q2 2026 in Review

Seascape Capital Management increased its Encompass Health (EHC) stake by 4.5% in Q2 2026, buying an estimated $138K and bringing the position to 31,122 shares worth $3.15M. The position accounts for 0.75% of the portfolio, ranked #48.

Seascape Capital Management first reported a position in EHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.33M in Q3 2025. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Seascape Capital Management held 31,122 shares of Encompass Health worth $3.15M as of Q2 2026.
  • Seascape Capital Management bought 1,334 Encompass Health shares in Q2 2026, an estimated $138K.
  • Encompass Health made up 0.75% of Seascape Capital Management's portfolio in Q2 2026, its #48 holding.
  • Seascape Capital Management first reported a position in Encompass Health in Q4 2024 and has held it in 7 quarters since.
  • Seascape Capital Management's Encompass Health position peaked at $3.33M in Q3 2025.
  • 599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Seascape Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.